Market Research Logo

US Market Report for Insulin 2017 - MedCore

US Market Report for Insulin 2017 - MedCore

The U.S. insulin market can be segmented by insulin type, yielding four segments: long-acting insulin, rapid-acting insulin, premixed insulin and human insulin. In 2016, the largest segment in the total insulin market was long-acting insulin. Patent expirations and the introduction of new products will lead to higher unit sales growth in this segment, relative to the rapid-acting insulin, premixed insulin and human insulin segments. Combined with steady appreciation of ASP, it is projected that long-acting insulin will be the fastest growing segment in the total insulin market over the forecast period. In terms of volume market share, premixed insulin represents the smallest portion of the total insulin market as well. It is expected that this trend will continue and ASP appreciation will follow the general upward trend of the total insulin market over the forecast period.

Insulin is a hormone that causes glucose uptake from the blood through the cells of the liver, muscle and fat tissue to be stored as glycogen in the liver and muscle. Type 1 diabetics’ immune systems destroy pancreatic beta cells: the only cells that can make insulin. The body therefore fails to produce insulin and cannot naturally convert food into energy. Type 2 diabetics have a resistance to insulin, and cells are not able to use the insulin present in the body. The need for insulin increases to the point that the pancreas can no longer produce it. Insulin is therefore a mode of treating both type 1 and type 2 diabetes.


EXECUTIVE SUMMARY
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 INTRODUCTION
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
INSULIN MARKET
3.1 INTRODUCTION
3.1.1 Insulin Types
3.1.1.1 Rapid-Acting Insulin Analogs
3.1.1.2 Regular Human Insulin
3.1.1.3 Intermediate-Acting Human Insulin
3.1.1.4 Long-Acting Insulin Analogs
3.1.1.5 Ultra-Long-Acting Insulin Analogs
3.1.1.6 Premixed Insulin
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Insulin Market
3.3.1.1 Long-Acting Insulin Market
3.3.1.2 Rapid-Acting Insulin Market
3.3.1.3 Premixed Insulin Market
3.3.1.4 Human Insulin Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023
Chart 3 1: Insulin Market by Segment, U.S., 2013 – 2023
Chart 3 2: Insulin Market Breakdown, U.S., 2016
Chart 3 3: Insulin Market Breakdown, U.S.,2023
Chart 3 4: Total Insulin Market, U.S., 2013 – 2023
Chart 3 5: Long-Acting Insulin Market, U.S., 2013 – 2023
Chart 3 6: Rapid-Acting Insulin Market, U.S., 2013 – 2023
Chart 3 7: Premixed Insulin Market, U.S., 2013 – 2023
Chart 3 8: Human Insulin Market, U.S., 2013 – 2023
Chart 3 9: Leading Competitors, Insulin Market, U.S., 2016
List of Figures
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2)
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2)
Figure 1 11: Key Report Updates
Figure 1 12: Version History
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016
Figure 7 1: Onset, Peak and Duration of Insulin Types, U.S., 2016
Figure 3 2: Insulin Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 3 3: Total Insulin Market, U.S., 2013 – 2023
Figure 3 4: Long-Acting Insulin Market, U.S., 2013 – 2023
Figure 3 5: Rapid-Acting Insulin Market, U.S., 2013 – 2023
Figure 3 6: Premixed Insulin Market, U.S., 2013 – 2023
Figure 3 7: Human Insulin Market, U.S., 2013 – 2023
Figure 3 8: Drivers and Limiters, Insulin Market, U.S., 2016
Figure 3 9: Leading Competitors, Insulin Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report